Catalent Mti Pharma Solutions Limited
- Active
- Large
- 13 years
- 54m+
- Real address
- 3 directors
- No owners
- Swindon
Two conditions of three:
1.Turnover > £36 million
2.Balance sheet total > £18 million
3.Average number of employees > 250
Field of Operation
Summary
Catalent Mti Pharma Solutions Limited is a private limited company registered in England/Wales with the registration number 08338674. The company was founded thirteen years ago on December 20, 2012, and registered at SN5 8YG, England, Swindon, Wiltshire, , Frankland Road, Blagrove. The address is probably real as only three companies are registered at the same address. Its status is active. The company operates in the processing & manufacturing, the professional services, the pharma, the scientific and technical r&d, the basic pharma industries. Officially, it has not published owners as their shares less than twenty five percent for each shareholder. It has three directors and no number of employees published.
It's a large company as it met two conditions of three: turnover more than £36 million, balance sheet more than £18 million, employees more than 250.
WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.
Managers
-
Individual
- 7 months
- 1
-
Resident of United Kingdom
-
Individual
- 10 months
- 11
-
Resident of United States
-
Individual
- 10 months
- 3
-
Resident of United States
Last reports
The latest confirmation statement submitted five months ago.
Last news
-
Appointment of Mr. Giuseppe Elia as a director on 2025-11-12Download 2 pages pdf report
-
Confirmation statement made on 2025-12-31 with updatesDownload 4 pages pdf report
-
Appointment of Mr. Ricky Hopson as a director on 2025-08-29Download 2 pages pdf report
FAQ about Catalent Mti Pharma Solutions Limited
Looking for leads in the UK?
Book a demo—see how CorpSignals can help you find UK leads.